Diabetic nephropathy is a complication of diabetes that affects the kidneys. Hyperkalemia refers to high levels of potassium in the blood. Damage to the kidneys can result in hyperkalemia. Diabetic ...

Hyperkalemia is a serious, often life threatening complication of diabetes-related kidney disease. This is one of the most common electrolyte imbalances experienced by people with kidney disease, or ...

When you have too much potassium in your blood, it’s called hyperkalemia. There are two types of hyperkalemia: acute and chronic. Acute hyperkalemia is a sudden, severe rise in blood potassium levels.

The investigational aldosterone synthase inhibitor lorundrostat demonstrated efficacy in reducing systolic blood pressure and albuminuria for patients with uncontrolled hypertension and chronic kidney ...

Hyperkalemia is common among elderly patients and is associated with an increase in morbidity and mortality. Patients at highest risk for developing hyperkalemia are those with chronic kidney disease ...

July 7, 2010 — Use of trimethoprim-sulfamethoxazole (TMP-SMX) may increase risk for hyperkalemia requiring hospitalization in older adults, but there is no added risk when used in combination with ...

Angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers are used commonly in clinical practice to treat hypertension and decrease cardiovascular events in high-risk patients.

If you have hyperkalemia, you have high levels of potassium in your blood. If you don’t get your potassium under control, the condition can be life-threatening. That’s why it’s important to advocate ...

Hyperkalemia is a potentially serious condition that can result in life-threatening cardiac arrhythmias and is associated with an increased mortality risk. Patients older than 65 years who have an ...

Searching for effective treatment options for 'Hyperkalemia symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

The Randomized Aldactone Evaluation Study (RALES) demonstrated that spironolactone significantly improves outcomes in patients with severe heart failure. Use of angiotensin-converting–enzyme (ACE) ...